Suppr超能文献

在埃塞俄比亚西北部的费莱格·希沃特转诊医院,使用献血者血清通过第四代酶联免疫吸附测定法对Determine HIV-1/2快速诊断检测进行评估。

Evaluation of Determine HIV-1/2 rapid diagnostic test by 4th generation ELISA using blood donors' serum at Felege Hiwot Referral Hospital, northwest Ethiopia.

作者信息

Dessie Azene, Abera Bayeh, Walle Fisseha, Wolday Dawit, Tamene Wogenie

机构信息

Departement of Paediatrics and Child Health, Felege Hiwot Referral Hospital, Bahir Dar, Ethiopia.

出版信息

Ethiop Med J. 2008 Jan;46(1):1-5.

Abstract

OBJECTIVE

The study aims to evaluate the HIV-1/2 rapid diagnostic test kit is routinely used to screen HIV infection for safe blood transfusion and VCT services in many parts of Ethiopia.

METHODS

A total of 324 sera were collected from consecutive blood donors from February to May 2006. All samples were screened for HIV infection using Determine HIV-1/2 (Abbott Japan) at hospital blood bank laboratory. Blindly, all serums were retested at Regional Health Research Laboratory using 4th generation ELISA (Vironostika HIV Uni-Form II AG/Ab) and Determine HIV-1/2 (Abbott lab). Discordant samples were repeatedly retested using the same ELISA and Determine HIV-1/2 to avoid technical errors. Finally, discordant results were resolved using Western Blot at the National HIV/AIDS Laboratory.

RESULTS

Determine HIV-1/2 and ELISA showed 94.4% concordance in HIV antibody testing with fair Cohen's Kappa statistic value (0.68) among blood donors. The sensitivity, specificity, positive and negative predictive values of Determine HIV-1/2 were 60.5%, 98.9%, 88.5% and 94.9% respectively.

CONCLUSION

As a rapid HIV screening test for blood donors, Determine HIV-1/2 showed poor sensitivity. Further evaluation at multiple centres is recommended to test its validity as a routine HIV screening test in blood donors. Use of a combination of rapid assays is also recommended for screening of HIV infection among the donor population.

摘要

目的

本研究旨在评估在埃塞俄比亚许多地区常规用于安全输血和自愿咨询检测服务中筛查HIV感染的HIV-1/2快速诊断试剂盒。

方法

2006年2月至5月从连续的献血者中总共采集了324份血清。所有样本在医院血库实验室使用Determine HIV-1/2(雅培日本公司)进行HIV感染筛查。所有血清在地区卫生研究实验室使用第四代酶联免疫吸附测定法(Vironostika HIV Uni-Form II AG/Ab)和Determine HIV-1/2(雅培实验室)进行盲法复测。对不一致的样本使用相同的酶联免疫吸附测定法和Determine HIV-1/2进行反复复测以避免技术误差。最后,在国家HIV/AIDS实验室使用免疫印迹法解决不一致的结果。

结果

在献血者中,Determine HIV-1/2和酶联免疫吸附测定法在HIV抗体检测中的一致性为94.4%,科恩kappa统计值适中(0.68)。Determine HIV-1/2的灵敏度、特异性、阳性预测值和阴性预测值分别为60.5%、98.9%、88.5%和94.9%。

结论

作为献血者的快速HIV筛查检测,Determine HIV-1/2显示出较差的灵敏度。建议在多个中心进行进一步评估,以测试其作为献血者常规HIV筛查检测的有效性。还建议使用多种快速检测方法组合对献血人群进行HIV感染筛查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验